Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1157]
News [2523]
Articles [155]
Editorials [8]
Conferences [103]
elearning [18]
Improving the management of senior adults with prostate cancer
Prof Amit Bahl, Prof Nicolas Mottet, Prof Jean-Pierre Droz and Henriette Breunis
Improving the management of senior adults with prostate cancer ( Prof Amit Bahl, Prof Nicolas Mottet, Prof Jean-Pierre Droz and Henriette Breunis )
21 Nov 2018
TRITON2: Evaluation of rucaparib in patients with metastatic castration...
Dr Josep Piulats - IDIBELL, Barcelona, Spain
TRITON2: Evaluation of rucaparib in patients with metastatic castration-resistant prostate cancer ( Dr Josep Piulats - IDIBELL, Barcelona, Spain )
26 Oct 2018
IMpower132: atezolizumab, carboplatin and pemetrexed as first line treatment in...
Dr Fabrice Barlesi - Aix-Marseille University, Marseille, France
IMpower132: atezolizumab, carboplatin and pemetrexed as first line treatment in key subgroups with stage IV non-squamous NSCLC ( Dr Fabrice Barlesi - Aix-Marseille University, Marseille, France )
25 Oct 2018
Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic...
Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah
Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic profiling of tissue and circulating tumour DNA ( Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah )
25 Oct 2018
Key developments in prostate cancer
Prof Nicholas James, Prof Karim Fizazi, Prof Matthew Smith, Prof Álvaro Pinto...
Key developments in prostate cancer ( Prof Nicholas James, Prof Karim Fizazi, Prof Matthew Smith, Prof Álvaro Pinto and Dr Mark Beresford )
22 Oct 2018
Assessing radiotherapy for men with newly diagnosed metastatic prostate cancer
Dr Chris C. Parker - The Royal Marsden, London, UK
Assessing radiotherapy for men with newly diagnosed metastatic prostate cancer ( Dr Chris C. Parker - The Royal Marsden, London, UK )
22 Oct 2018
ESMO 2018: Highlights
Prof Gordon McVie , Will Davies
ESMO 2018: Highlights ( Prof Gordon McVie , Will Davies )
22 Oct 2018
Latest advances in precision medicine for prostate and bladder cancer
Prof Thomas Powles, Prof Matthew Galsky, Prof Bertrand Tombal
Latest advances in precision medicine for prostate and bladder cancer ( Prof Thomas Powles, Prof Matthew Galsky, Prof Bertrand Tombal )
22 Oct 2018
Comment on the JAVELIN study: RCC immunotherapy
Prof John Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands
Comment on the JAVELIN study: RCC immunotherapy ( Prof John Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands )
21 Oct 2018
Comment: Radiotherapy as a treatment option for metastatic prostate cancer
Dr Ignacio Duran - Hospital Universitario Virgen del Rocío, Sevilla, Spain
Comment: Radiotherapy as a treatment option for metastatic prostate cancer ( Dr Ignacio Duran - Hospital Universitario Virgen del Rocío, Sevilla, Spain )
21 Oct 2018
JAVELIN Renal 101 trial: avelumab and axitinib for advanced renal cell carcinoma
Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA
JAVELIN Renal 101 trial: avelumab and axitinib for advanced renal cell carcinoma ( Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA )
21 Oct 2018
Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA
Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma ( Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA )
21 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation